Cargando…
Interleukin-6 inhibitors reduce mortality in coronavirus disease-2019: An individual patient data meta-analysis from randomized controlled trials
OBJECTIVE: To assess the efficacy of IL-6 inhibitors compared to standard of care (SOC) in COVID-19 patients. DATA SOURCES: A systematic review of the MEDLINE and Scopus databases (last search: October 8(th), 2021) was performed according to the PRISMA statement. STUDY SELECTION: Randomized control...
Autores principales: | Tasoudis, Panagiotis T., Arvaniti, Christina K., Adamou, Anastasia T., Belios, Ioannis, Stone, John H., Horick, Nora, Sagris, Dimitrios, Dalekos, George N., Ntaios, George |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Federation of Internal Medicine. Published by Elsevier B.V.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8986475/ https://www.ncbi.nlm.nih.gov/pubmed/35422374 http://dx.doi.org/10.1016/j.ejim.2022.04.004 |
Ejemplares similares
-
Immunomodulation and Reduction of Thromboembolic Risk in Hospitalized COVID-19 Patients: Systematic Review and Meta-Analysis of Randomized Trials
por: Sagris, Dimitrios, et al.
Publicado: (2021) -
Self-reported risk of obstructive sleep apnea syndrome, and awareness about it in the community of 4 insular complexes comprising 41 Greek Islands
por: Adamou, Anastasia, et al.
Publicado: (2022) -
Dabigatran Reversal With Idarucizumab and In-Hospital Mortality in Intracranial Hemorrhage: A Systematic Review of Real-Life Data From Case Reports and Case Series
por: Frol, Senta, et al.
Publicado: (2021) -
Intravenous Thrombolysis After Dabigatran Reversal by Idarucizumab: A Systematic Review of the Literature
por: Frol, Senta, et al.
Publicado: (2021) -
Soluble IL-2R Levels at Baseline Predict the Development of Severe Respiratory Failure and Mortality in COVID-19 Patients
por: Gatselis, Nikolaos K., et al.
Publicado: (2022)